Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19.
Mazzotta V, Cozzi-Lepri A, Colavita F, Lanini S, Rosati S, Lalle E, Mastrorosa I, Cimaglia C, Vergori A, Bevilacqua N, Lapa D, Mariano A, Bettini A, Agrati C, Piselli P, Girardi E, Castilletti C, Garbuglia AR, Vaia F, Nicastri E, Antinori A. Mazzotta V, et al. Among authors: nicastri e. Front Immunol. 2022 Apr 20;13:868020. doi: 10.3389/fimmu.2022.868020. eCollection 2022. Front Immunol. 2022. PMID: 35514955 Free PMC article. Clinical Trial.
HIV infection among low-risk first lifetime testers in Rome, 1990-2000.
Galati V, Serraino D, Puro V, Orchi N, De Carli G, Scognamiglio P, Nicastri E, Piselli P, Nurra G, Angeletti C, Girardi E, Ippolito G. Galati V, et al. Among authors: nicastri e. Infection. 2005 Apr;33(2):61-5. doi: 10.1007/s15010-005-4040-5. Infection. 2005. PMID: 15827872
Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.
Zaccarelli M, Lorenzini P, Tozzi V, Forbici F, Ceccherini-Silberstein F, Gori C, D'Arrigo R, Trotta MP, Narciso P, Perno CF, Antinori A; Collaborative Group for Clinical Use of the HIV Genotype Resistance Test (GRT) at the National Institute for Infectious Diseases "Lazzaro Spallanzani". Zaccarelli M, et al. Infection. 2009 Jun;37(3):203-9. doi: 10.1007/s15010-008-8142-8. Epub 2009 Mar 9. Infection. 2009. PMID: 19274429
Accuracy of malaria diagnosis by microscopy, rapid diagnostic test, and PCR methods and evidence of antimalarial overprescription in non-severe febrile patients in two Tanzanian hospitals.
Nicastri E, Bevilacqua N, Sañé Schepisi M, Paglia MG, Meschi S, Ame SM, Mohamed JA, Mangi S, Fumakule R, Di Caro A, Capobianchi MR, Kitua A, Molteni F, Racalbuto V, Ippolito G. Nicastri E, et al. Am J Trop Med Hyg. 2009 May;80(5):712-7. Am J Trop Med Hyg. 2009. PMID: 19407111
Healthcare-associated infection in Italy: annual point-prevalence surveys, 2002-2004.
Lanini S, Jarvis WR, Nicastri E, Privitera G, Gesu G, Marchetti F, Giuliani L, Piselli P, Puro V, Nisii C, Ippolito G; INF-NOS Study Group (Gruppo Italiano per lo Studio delle Infezioni Noscomiali). Lanini S, et al. Among authors: nicastri e. Infect Control Hosp Epidemiol. 2009 Jul;30(7):659-65. doi: 10.1086/597596. Infect Control Hosp Epidemiol. 2009. PMID: 19496645
The prevalence of antibodies to human herpesvirus 8 and hepatitis B virus in patients in two hospitals in Tanzania.
Meschi S, Schepisi MS, Nicastri E, Bevilacqua N, Castilletti C, Sciarrone MR, Paglia MG, Fumakule R, Mohamed J, Kitwa A, Mangi S, Molteni F, Di Caro A, Vairo F, Capobianchi MR, Ippolito G. Meschi S, et al. Among authors: nicastri e. J Med Virol. 2010 Sep;82(9):1569-75. doi: 10.1002/jmv.21852. J Med Virol. 2010. PMID: 20648611 Free article.
Viral hemorrhagic fevers: advancing the level of treatment.
Ippolito G, Feldmann H, Lanini S, Vairo F, Di Caro A, Capobianchi MR, Nicastri E. Ippolito G, et al. Among authors: nicastri e. BMC Med. 2012 Mar 29;10:31. doi: 10.1186/1741-7015-10-31. BMC Med. 2012. PMID: 22458265 Free PMC article. Review.
408 results